Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HODGKIN LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02006485
What this trial is testing

Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma
TG Therapeutics, Inc. 160
Testing effectiveness (Phase 2)Looking for participantsNCT07042438
What this trial is testing

Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma+3 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06564038
What this trial is testing

AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukaemiaSmall Lymphocytic LymphomaMantle-cell Lymphoma+2 more
AstraZeneca 408
Not applicableLooking for participantsNCT06133426
What this trial is testing

Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients

Who this might be right for
Lymphoma, Non-HodgkinMyeloma Multiple
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07550855
What this trial is testing

Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Sun Yat-sen University 52
Very early researchStudy completedNCT03281811
What this trial is testing

Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides

Who this might be right for
Refractory Mycosis Fungoides
Mayo Clinic 11
Testing effectiveness (Phase 2)Study completedNCT00295932
What this trial is testing

Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 79
Testing effectiveness (Phase 2)Looking for participantsNCT07397832
What this trial is testing

CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Tianjin Medical University Cancer Institute and Hospital 58
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06544798
What this trial is testing

Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia

Who this might be right for
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
MeiraGTx, LLC 276
Testing effectiveness (Phase 2)Study completedNCT00076349
What this trial is testing

SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Cephalon 66
Not applicableLooking for participantsNCT06691698
What this trial is testing

Evaluation of CO-OP for Adolescents With Mild Intellectual Disability

Who this might be right for
Intellectual Disability, Mild
Örebro University, Sweden 60
Post-approval studies (Phase 4)Looking for participantsNCT06609304
What this trial is testing

Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Zhengzhou University 20
Testing effectiveness (Phase 2)Ended earlyNCT00003498
What this trial is testing

Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Burzynski Research Institute 5
Not applicableUnknownNCT04893538
What this trial is testing

Prognostic Value Of Lymphocyte Count and Lymphocyte/ Monocyte Ratio in Patients With Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma
Latakia University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07032532
What this trial is testing

Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)

Who this might be right for
Peripheral T Cell Lymphoma
Sun Yat-sen University 35
Large-scale testing (Phase 3)Study completedNCT01313221
What this trial is testing

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 310
Testing effectiveness (Phase 2)UnknownNCT05749549
What this trial is testing

Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers

Who this might be right for
Advanced CancerFollicular LymphomaPeripheral T Cell Lymphoma+1 more
Shanghai Blueray Biopharma Co., Ltd. 191
Not applicableStudy completedNCT01726387
What this trial is testing

Self-Management for Anxiety, Depression and Somatoform Disorders

Who this might be right for
Anxiety Depression (Mild or Not Persistent)Major Depressive Disorder, Single Episode, UnspecifiedNeurotic, Stress-related and Somatoform Disorders
Universitätsklinikum Hamburg-Eppendorf 364
Early research (Phase 1)Study completedNCT04067414
What this trial is testing

Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma+1 more
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Study completedNCT00901147
What this trial is testing

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma (Not Otherwise Specified)Angioimmunoblastic T-cell LymphomaExtranodal NK/T-cell Lymphoma Nasal Type+4 more
Singapore General Hospital 25
Next Page
56